IL174430A0 - Seneca valley virus based compositions and methods for treating disease - Google Patents
Seneca valley virus based compositions and methods for treating diseaseInfo
- Publication number
- IL174430A0 IL174430A0 IL174430A IL17443006A IL174430A0 IL 174430 A0 IL174430 A0 IL 174430A0 IL 174430 A IL174430 A IL 174430A IL 17443006 A IL17443006 A IL 17443006A IL 174430 A0 IL174430 A0 IL 174430A0
- Authority
- IL
- Israel
- Prior art keywords
- methods
- based compositions
- treating disease
- virus based
- valley virus
- Prior art date
Links
- 241000837158 Senecavirus A Species 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A61K35/768—Oncolytic viruses not provided for in groups A61K35/761 - A61K35/766
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/085—Picornaviridae, e.g. coxsackie virus, echovirus, enterovirus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32061—Methods of inactivation or attenuation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50618203P | 2003-09-26 | 2003-09-26 | |
| PCT/US2004/031504 WO2005030139A2 (en) | 2003-09-26 | 2004-09-23 | Seneca valley virus based compositions and methods for treating disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL174430A0 true IL174430A0 (en) | 2006-08-01 |
Family
ID=34393123
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL174430A IL174430A0 (en) | 2003-09-26 | 2006-03-21 | Seneca valley virus based compositions and methods for treating disease |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1668025B1 (enExample) |
| JP (1) | JP2007506434A (enExample) |
| KR (1) | KR20060103890A (enExample) |
| CN (1) | CN1875028B (enExample) |
| AU (1) | AU2004275832A1 (enExample) |
| BR (1) | BRPI0414810A (enExample) |
| CA (1) | CA2540177A1 (enExample) |
| DK (1) | DK1668025T3 (enExample) |
| IL (1) | IL174430A0 (enExample) |
| MX (1) | MXPA06003318A (enExample) |
| SG (1) | SG149069A1 (enExample) |
| WO (1) | WO2005030139A2 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPQ425699A0 (en) | 1999-11-25 | 1999-12-23 | University Of Newcastle Research Associates Limited, The | A method of treating a malignancy in a subject and a pharmaceutical composition for use in same |
| AU2002953436A0 (en) | 2002-12-18 | 2003-01-09 | The University Of Newcastle Research Associates Limited | A method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis |
| US7638318B2 (en) | 2003-09-26 | 2009-12-29 | Norvartis Ag | Seneca Valley virus based compositions and methods for treating disease |
| WO2007047256A2 (en) * | 2005-10-13 | 2007-04-26 | Neotropix, Inc. | Svv-based animal vaccines and uses thereof |
| CA3045771A1 (en) | 2015-12-02 | 2017-06-08 | Memorial Sloan-Kettering Cancer Center | Seneca valley virus (svv) cellular receptor targeted oncotherapy |
| CN105925728B (zh) * | 2016-06-01 | 2019-09-20 | 华南农业大学 | 一种塞内加谷病毒实时荧光定量pcr检测引物及试剂盒 |
| US10323069B2 (en) * | 2016-08-23 | 2019-06-18 | Regents Of The University Of Minnesota | Senecavirus A antigens and methods of use |
| EP3652325A4 (en) * | 2017-07-14 | 2021-09-15 | Oncorus, Inc. | ENCAPSULATED POLYNUCLEOTIDES AND METHODS OF USE |
| CN107253978B (zh) * | 2017-08-13 | 2020-11-20 | 中牧实业股份有限公司 | 塞尼卡谷病毒结构蛋白抗体酶联免疫检测试剂盒 |
| CN107513524B (zh) * | 2017-09-30 | 2021-02-09 | 中牧实业股份有限公司 | 一株猪塞内加谷病毒毒株及其应用 |
| CN108467904B (zh) * | 2018-05-24 | 2021-11-19 | 华南农业大学 | 检测塞尼卡谷病毒的rt-lamp引物组、试剂盒及应用 |
| CN109182278B (zh) * | 2018-10-12 | 2021-08-06 | 河南省动物疫病预防控制中心 | 塞尼卡谷病毒毒株及其应用 |
| SG11202104887UA (en) * | 2018-11-13 | 2021-06-29 | Oncorus Inc | Encapsulated polynucleotides and methods of use |
| CN109234464A (zh) * | 2018-11-23 | 2019-01-18 | 山东新希望六和集团有限公司 | 用于检测塞尼卡谷病毒的引物及探针、荧光定量pcr试剂盒及方法和应用 |
| CN111733144A (zh) * | 2019-03-25 | 2020-10-02 | 金宇保灵生物药品有限公司 | 一种塞内卡病毒的纯化方法及病毒液的浓缩纯化方法 |
| CN112433049B (zh) * | 2019-06-24 | 2023-08-18 | 中国动物疫病预防控制中心(农业农村部屠宰技术中心) | 检测塞内卡病毒抗体的试剂及其应用 |
| BR112022000928A2 (pt) | 2019-07-19 | 2022-03-08 | Seneca Therapeutics Inc | Terapia oncolítica do vírus seneca valley de segunda geração: composições e métodos da mesma |
| CN110923211A (zh) * | 2019-12-25 | 2020-03-27 | 哈药集团生物疫苗有限公司 | 塞内卡病毒分离株、塞内卡病毒病灭活疫苗及其制备方法 |
| CN111286491A (zh) * | 2020-02-03 | 2020-06-16 | 河南省动物疫病预防控制中心 | 猪塞内卡病毒核酸标准物及其应用 |
| CN111849925B (zh) * | 2020-07-06 | 2022-06-03 | 马忠仁 | 一种抗结肠癌疫苗及其制法 |
| CN111798712B (zh) * | 2020-07-15 | 2021-10-29 | 周晓庆 | 噬菌体侵染细菌3d智能模拟方法 |
| CN111944764A (zh) * | 2020-08-31 | 2020-11-17 | 信阳农林学院 | 一种表达猪塞内加谷病毒蛋白的细胞系、构建方法和应用 |
| CN112390861A (zh) * | 2020-09-30 | 2021-02-23 | 信阳农林学院 | 表达猪塞内加谷病毒vp1蛋白的细胞系、构建方法和应用 |
| CN117281824B (zh) * | 2023-08-11 | 2025-10-21 | 华南农业大学 | Trim基因的过表达剂在制备抑制猪塞内卡病毒复制的产品中的应用 |
| CN117487006B (zh) * | 2023-12-29 | 2024-04-12 | 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） | 一种抗a型塞内卡病毒的单克隆抗体以及抗原表位及应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6110461A (en) * | 1997-08-13 | 2000-08-29 | Oncolytics Biotech Inc. | Reovirus for the treatment of neoplasia |
-
2004
- 2004-09-23 EP EP04789044.7A patent/EP1668025B1/en not_active Expired - Lifetime
- 2004-09-23 CN CN200480030443XA patent/CN1875028B/zh not_active Expired - Lifetime
- 2004-09-23 AU AU2004275832A patent/AU2004275832A1/en not_active Abandoned
- 2004-09-23 BR BRPI0414810-0A patent/BRPI0414810A/pt not_active IP Right Cessation
- 2004-09-23 JP JP2006528260A patent/JP2007506434A/ja active Pending
- 2004-09-23 SG SG200809634-9A patent/SG149069A1/en unknown
- 2004-09-23 WO PCT/US2004/031504 patent/WO2005030139A2/en not_active Ceased
- 2004-09-23 DK DK04789044.7T patent/DK1668025T3/da active
- 2004-09-23 KR KR1020067008081A patent/KR20060103890A/ko not_active Withdrawn
- 2004-09-23 CA CA002540177A patent/CA2540177A1/en not_active Abandoned
- 2004-09-23 MX MXPA06003318A patent/MXPA06003318A/es unknown
-
2006
- 2006-03-21 IL IL174430A patent/IL174430A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1875028B (zh) | 2012-07-04 |
| EP1668025A4 (en) | 2007-05-16 |
| BRPI0414810A (pt) | 2006-11-14 |
| SG149069A1 (en) | 2009-01-29 |
| CN1875028A (zh) | 2006-12-06 |
| DK1668025T3 (da) | 2014-08-25 |
| KR20060103890A (ko) | 2006-10-04 |
| JP2007506434A (ja) | 2007-03-22 |
| WO2005030139A3 (en) | 2005-10-20 |
| HK1094583A1 (en) | 2007-04-04 |
| AU2004275832A1 (en) | 2005-04-07 |
| CA2540177A1 (en) | 2005-04-07 |
| EP1668025B1 (en) | 2014-06-25 |
| WO2005030139A2 (en) | 2005-04-07 |
| EP1668025A2 (en) | 2006-06-14 |
| MXPA06003318A (es) | 2006-06-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL174430A0 (en) | Seneca valley virus based compositions and methods for treating disease | |
| PL1771201T3 (pl) | Kompozycje i sposoby leczenia lub profilaktyki choroby związanej ze szczawianem | |
| PL1965816T3 (pl) | Kompozycje farmaceutyczne i sposoby leczenia lub zapobiegania chorobom związanym ze szczawianami | |
| EP1545578A4 (en) | COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR DISEASES | |
| IL240410A0 (en) | Hemolytic disease treatment method | |
| EP1667730A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATORY PULMONARY DISEASE | |
| PL380828A1 (pl) | Fosfoniany, amidomonofosfoniany, amidobisfosfoniany do leczenia chorób wirusowych | |
| MY143799A (en) | Compositions and methods for treating diabetes | |
| EP1668024A4 (en) | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES INCLUDING INFLAMMATORY SUFFERING | |
| DE60307766D1 (de) | Gewürzmittel und Verfahren zu seiner Herstellung | |
| EP1680145A4 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEUROLOGICAL DISEASES | |
| AU2003212850A8 (en) | Methods and compositions for treating cardiovascular disease | |
| GB0320238D0 (en) | Treatment of disease | |
| AU2003236156A1 (en) | Pharmaceutical compositions used for immune disease treatment and improvement | |
| EP1667999A4 (en) | BENZOPYRANONE COMPOUNDS, COMPOSITIONS THEREOF, AND TREATMENT METHOD USING THE SAME | |
| EP1583966A4 (en) | METHODS AND COMPOSITIONS FOR TREATING CARDIOVASCULAR DISEASES USING GENES 1722, 10280, 59917, 85553, 10653, 9235, 21668, 17794, 2210, 6169, 10102, 21061, 17662, 1468, 12282, 6350, 9035, 1820, 23652, 7301, 8925, 8701, 3533, 9462, 9123, 12788, 17729, 65552, 1261, 21476, 33770, 9380, 2569654, 33 | |
| ZA200602738B (en) | Methods and compositions for treating herpes infections | |
| AU2003243663A8 (en) | Vaccines for suppressing ige-mediated allergic disease and methods for using the same | |
| AU2003259202A8 (en) | Compositions and methods for treating and preventing infection | |
| IL175369A0 (en) | Novel compound, corresponding compositions, preparation and/or treatment methods | |
| AU2003237088A8 (en) | Compounds, compositions and methods for treating or preventing viral infections and associated diseases | |
| AU2002342188A8 (en) | Methods and compositions for treating flavivirus-mediated disease | |
| HK1111919A (en) | Seneca valley virus based compositions and methods for treating disease | |
| GB0517911D0 (en) | Infected poultry treatment system and method thereof | |
| AU2003248679A8 (en) | Treating disease using radium-225 |